Mark Poritz
Hoofd Techniek/Wetenschap/O&O bij CO-DIAGNOSTICS, INC.
Actieve functies van Mark Poritz
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CO-DIAGNOSTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2022 | - |
Loopbaan van Mark Poritz
Eerdere bekende functies van Mark Poritz
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Idaho Molecular, Inc.
 Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Mark Poritz
| Harvard College | Undergraduate Degree |
| University of California | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CO-DIAGNOSTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Idaho Molecular, Inc.
Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Health Technology |
- Beurs
- Insiders
- Mark Poritz
- Ervaring